Two minor NQO1 and NQO2 alleles predict poor response of breast cancer patients to adjuvant doxorubicin and cyclophosphamide therapy-Reference-Cited by-同舟云学术

Two minor NQO1 and NQO2 alleles predict poor response of breast cancer patients to adjuvant doxorubicin and cyclophosphamide therapy

Published:2011-12 Issue:12 Volume:21 Page:808-819
ISSN:1744-6872
Container-title:Pharmacogenetics and Genomics
language:en
Short-container-title:

Author:

Jamieson David,Cresti Nicola,Bray Johanne,Sludden Julieann,Griffin Melanie J.,Hawsawi Nahed M.,Famie Eve,Mould Emily V.A.,Verrill Mark W.,May Felicity E.B.,Boddy Alan V.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine,General Pharmacology, Toxicology and Pharmaceutics

Reference37 articles.

1. NAD(P)H-Quinone Oxidoreductase(1) (DT-Diaphorase) expression in normal and tumor-tissues.;Belinsky;Cancer Metastasis Rev,1993

2. Functional polymorphisms, altered gene expression and genetic association link NRH:quinone oxidoreductase 2 to breast cancer with wild-type p53.;Yu;Hum Mol Genet,2009

3. DT-diaphorase as a quinone reductase: a cellular control device against semiquinone and superoxide radical formation.;Lind;Arch Biochem Biophys,1982

4. Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase.;Wu;Arch Biochem Biophysics,1997

5. Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1.;Asher;Proc Natl Acad Sci USA,2001

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of ALDH1A1 and NQO1 gene polymorphisms on the response and toxicity of chemotherapy in Bangladeshi breast cancer patients;Cancer Chemotherapy and Pharmacology;2024-07-16

2. Polymorphisms and Pharmacogenomics of NQO2: The Past and the Future;Genes;2024-01-10

3. Pharmacogenetic Profiling in High-Risk Soft Tissue Sarcomas Treated with Neoadjuvant Chemotherapy;Journal of Personalized Medicine;2022-04-11

4. Single Nucleotide Polymorphisms as the Efficient Prognostic Markers in Breast Cancer;Current Cancer Drug Targets;2021-10

5. Genetic polymorphisms on the effectiveness or safety of breast cancer treatment: Clinical relevance and future perspectives;Mutation Research/Reviews in Mutation Research;2021-07